Tag: generics

Understand the key differences between biosimilars and generics, including FDA approval pathways, interchangeability rules, and strategies for provider education to improve patient care.

Pharmacists must stay current on generics to prevent substitution errors and ensure patient safety. With 90% of prescriptions filled with generics, continuing education on therapeutic equivalence, state laws, and biosimilars is critical - not optional.

Specialty pharmacy handles high-cost, complex medications where generics and biosimilars are changing the game. Learn how pharmacists manage substitution, patient concerns, PBM pressures, and the growing role of biosimilars in chronic disease care.